Results 301 to 310 of about 310,541 (331)
Some of the next articles are maybe not open access.

NASH and HCC

Clinics in Liver Disease, 2009
Primary liver cancer is the fifth most common malignancy worldwide and the third leading cause of cancer mortality. Non-alcoholic fatty liver disease is the most common cause of chronic liver disease in the United States encompassing a spectrum of entities marked by hepatic steatosis in the absence of significant alcohol consumption.
John M, Page, Stephen A, Harrison
openaire   +2 more sources

HCC therapies—lessons learned

Nature Reviews Gastroenterology & Hepatology, 2014
The antiangiogenic multikinase inhibitor sorafenib was the first systemic agent to demonstrate a significant improvement in the overall survival of patients with advanced hepatocellular carcinoma (HCC), thereby introducing molecularly-targeted therapy in a therapeutic field of unmet needs.
Marcus-Alexander, Wörns   +1 more
openaire   +2 more sources

HCC

Journal of Vascular and Interventional Radiology, 2005
  +5 more sources

HCC

Oncology Times, 2014
openaire   +2 more sources

HCC

2009
Dieter Metze   +199 more
openaire   +2 more sources

HCC You Cannot See

Digestive Diseases and Sciences, 2021
Vaishnavi, Boppana   +4 more
openaire   +2 more sources

Diagnostyka HCC

2023
Barbara Górnicka   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy